Navigation Links
Boston Strategic Partners, Inc. is Utilizing Electronic Health Record Data to Analyze Hospital Treated Pneumonia
Date:9/14/2017

Boston Strategic Partners, Inc. (BSP), a life-sciences and healthcare consulting firm is utilizing its extensive experience with Health Economics and Outcomes Research (HEOR) and ‘big data’ to provide in-depth analysis of pneumonia patients characteristics, medication management, costs and laboratory testing. In 2014, US healthcare spending exceeded $3.0 trillion with nearly 1/3 spent on hospitalizations. BSP has access to real-world data from an Electronic Health Record (EHR) database of clinical and administrative records spanning 273 million encounters for 60 million patients in 600+ hospitals and health systems across the US, representing nearly 16% of the US population.

30% of all hospital discharges involve treatment of infectious organisms. Pneumonia is responsible for an estimated 12% of all hospital stays. At an average cost of $15,500 per occurrence, we estimate that hospitalizations for severe infections account for $212 billion in annual spending or 7% of total healthcare expenditure. In this report, we conduct an in-depth analysis of sepsis patient characteristics, medication management, costs, and laboratory testing.

Gram-negative bacteria are the likely causative agents of most pneumonia infections and physicians treat most of these patients with levofloxacin, ceftriaxone, and azithromycin. From 2010-2015, drug resistant organisms caused a surprising 20% of bacterial pneumonia infections. After confirmatory diagnosis, over half of sepsis patients undergo a change in antibiotic therapy.
BSP provides quantitative, objective data using real-world patient encounters and reflects real physician decisions and encounter characteristics (e.g. patient response to therapy and outcomes) in key areas, such as antibiotic resistant pathogens and antimicrobial stewardship.

Areas of focus:

  •     Acute Myocardial Infarction
  •     Antibiotic resistance
  •     Chronic Kidney Disease (CKD)
  •     Chronic Obstructive Pulmonary Disease (COPD)
  •     Extrinsic Asthma
  •     Hip and knee surgery
  •     Hypertension
  •     Influenza (and resulting complications)
  •     Obesity
  •     Osteoarthritis
  •     Schizophrenia
  •     Stroke
  •     Type 2 Diabetes (and resulting complications)

For more information about Boston Strategic Partners, Inc. and our data analysis reports visit: http://www.bostonsp.com/reports.

About BSP
Founded in 2003, Boston Strategic Partners, Inc. is a dedicated healthcare and life sciences company. We offer five different types of services:

  •     Business & Clinical Strategy
  •     Health Economics & Outcomes Research (HEOR)
  •     Medical Communications
  •     Regulatory Strategy
  •     Financial Advisory

For more information or to schedule a meeting with our team, please email us at info(at)bostonsp(dot)com

Read the full story at http://www.prweb.com/releases/2017/09/prweb14690268.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. PRC Clinical Partners With SDC to Expand ClinPulse Event Series to the Boston Biotech Hub
2. Boston Strategic Partners, Inc. is utilizing Electronic Health Record Data for real world data analysis
3. 4 Strategic Takeaways from Open Data Science Conference 2017 in Boston
4. Stratevi Expands to East Coast with Boston Office Opening
5. Brainstorm Cell Therapeutics to Present at ARMs 5th Annual Cell & Gene Therapy Investor Day, April 27 in Boston
6. DrugDev Joins Boston’s Technology Trendsetters to Host MassTLC’s NewCo Festival in Boston
7. Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017
8. Boston Biomedical Celebrates 10-Year Anniversary of its Founding and Announces Appointment of Patricia S. Andrews as Chief Executive Officer
9. At 6th Annual Clinical Trial Supply New England 2017 Conference in Boston Asymmetrex Introduces A First Specific Quality Control Test for Therapeutic Tissue Stem Cells
10. Asymmetrex’s Head Will Lead Discussion on Supplying Private Stem Cell Clinics at the 6th Annual Clinical Trial Supply New England 2017 Conference in Boston
11. Boston Children’s Hospital and uBiome to Investigate Premature Births
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):